ALLERGAN INC·4

Jan 26, 6:08 PM ET

ROSSO LOUIS T 4

4 · ALLERGAN INC · Filed Jan 26, 2005

Insider Transaction Report

Form 4
Period: 2005-01-24
Transactions
  • Award

    Phantom Stock Units

    2005-01-24$77.25/sh+12.94$1,00021,929.84 total
    Common Stock (0 underlying)
  • Award

    Phantom Stock Units

    2005-01-25$76.00/sh+26.32$2,00021,969.1 total
    Common Stock (0 underlying)
Footnotes (3)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
  • [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.

Documents

1 file
  • 4
    ros346.xmlPrimary